What is Calquence?
Calquence is the brand name for the product acalabrutinib. It is a prescription drug used for the treatment of certain types of blood cancers, including mantle cell lymphoma and chronic lymphocytic leukemia. Calquence is classified as a Bruton’s tyrosine kinase (BTK) inhibitor, which works by blocking the BTK enzyme involved in the growth and survival of cancer cells.
By inhibiting BTK, Calquence helps slow down or stop the growth of cancer cells, leading to the reduction of tumor size and progression of the disease. It is typically taken orally in capsule form, with the dosage and frequency determined by a healthcare provider based on the specific type and stage of the blood cancer being treated.
Difference between the Calquence capsules and the tablets?
Calquence has transitioned from capsules to tablets, allowing compatibility with stomach acid-reducing product. Safety and efficacy remain consistent between the tablet and capsule forms.
The dosage remains at one 100-mg tablet orally twice daily, approximately every 12 hours, with or without food. It’s important not to mix or interchange tablets and capsules. If still using capsules, continue to avoid proton pump inhibitors and time intake with H2-receptor blockers and antacids as directed.
Information you should know about Calquence
Calquence is a production used for the treatment of certain types of blood cancers, including mantle cell lymphoma and chronic lymphocytic leukemia.
It is a Bruton’s tyrosine kinase (BTK) inhibitor that works by blocking the BTK enzyme involved in the growth and survival of cancer cells.
Calquence helps slow down or stop the growth of cancer cells, leading to the reduction of tumor size and progression of the disease.
The production is typically taken orally in capsule form, with the dosage and frequency determined by a healthcare provider based on the specific type and stage of the blood cancer being treated.
Recommended dosage for Calquence
The recommended dosage of Calquence for the treatment of mantle cell lymphoma and chronic lymphocytic leukemia typically involves taking 100 mg orally twice daily.
UBRELVY (generic ubrogepant)
What is Ubrelvy?
Ubrelvy, containing ubrogepant, is available in 50mg and 100mg tablets for treating acute migraines in adults. Ubrogepant blocks CGRP from binding to nervous system receptors, potentially relieving migraines by reducing vasodilation, inflammation, and pain associated with CGRP release during attacks.
Information you should know about Ubrelvy:
Ubrelvy is distributed by AbbVie Corporation in Canada and is a trademark of Allergan Pharmaceuticals International Limited.
Ubrelvy is available as 50 mg and 100 mg ubrogepant tablets from our mail order Canadian pharmacy.
Ubrelvy is not indicated for use in children and use with caution in adults aged 65 and older.
Ubrelvy is stored at room temperature, between 15°C and 30°C.
What is the recommended dose for Ubrelvy ?
Recommended starting dose of Ubrogepant is 50mg or 100mg taken orally as needed.
A second dose can be taken, if necessary, with a minimum two-hour gap from the initial dose.
Maximum daily dose should not exceed 200mg. Dosage adjustments may be necessary for patients with liver or kidney disease.
APREMILAST (generic Otezla)
What is Apremilast?
Apremilast is the generic form of Otezla, a prescription product used to treat certain types of inflammatory conditions, including psoriasis and psoriatic arthritis. It is a phosphodiesterase-4 (PDE-4) inhibitor that works by targeting specific enzymes in the body involved in inflammation and the immune response.
Apremilast helps to reduce the signs and symptoms of psoriasis, such as red, scaly patches on the skin, and can also improve joint pain and swelling associated with psoriatic arthritis. It is available in tablet form and is typically taken orally once or twice daily as directed by a healthcare provider.
Information you should know about apremilast
It comes in of 10mg and 30mg tablets, generic alternative to Otezla
Apremilast is a prescription product used to treat certain inflammatory conditions like psoriasis and psoriatic arthritis.
The product is available in tablet form and is typically taken orally once or twice daily as prescribed.
It is a phosphodiesterase-4 (PDE-4) inhibitor that targets enzymes involved in inflammation and the immune response.
Apremilast helps reduce symptoms of psoriasis, such as red, scaly skin patches, and can improve joint pain and swelling in psoriatic arthritis.
Recommended dosage for apremilast
The recommended dosage of apremilast typically involves starting with a lower dose, such as 10mg, and gradually increasing to the standard maintenance dose of 30mg twice daily.
For inquiries about prescription medications, contact our team at Jason’s CanadaDrugstore.com by calling 1-800-226 3784 (CAN-DRUG) for assistance from our patient representatives or a licensed Canadian pharmacist.
This article provides medical information to help understand a condition or treatment plan but is not a diagnosis or treatment recommendation. Contact your doctor if you have concerns or symptoms. In case of emergency, call 911.
Leave a Reply